Emi H. Caywood, MD
Hematology/OncologyInsurance Accepted
- Aetna Better Health PA Kids HMO
- Aetna HMO
- Aetna PPO/POS/EPO
- Amerihealth Caritas DE - PENNSYLVANIA SPECIALISTS ONLY
- Amerihealth Caritas Delaware
- Carefirst MD Community Health Plan Mcaid
- Cigna/Great West HMO EPO POS
- Cigna/Great West PPO
- Delaware First Health
- Delaware Medicaid/Diamond State
- Delaware Medicare
- Devon Health Services
- Fidelis Care NJ Medicaid HMO
- First Health/Affordable PPO
- Geisinger Health Plan Commercial
- Global Medical Managment DE/PA
- Health Partners Medicaid/Kidz Partner HMO
- Highmark Blue Cross Blue Shield of Delaware
- Highmark Blue Cross Blue Shield of Pennsylvania
- Highmark Medicaid Health Options
- Horizon Blue Cross Blue Shield of New Jersey
- Independance Blue Cross/Amerihealth/Keystone Health Plan
- Insurance Administrators of America
- INTEGRA Administrative Group (ClaimsBridge)
- Interlink Transplant
- Keystone First Medicaid HMO
- Lifetrac Transplant
- Maryland Medicaid
- Multiplan PPO
- New Jersey Medicaid
- Pennsylvania Medicaid
- Plan Vista/NPPN PPO
- Preferred Healthcare PPO
- Private Health Care Systems (PHCS)
- Qualcare HMO/POS/PPO
- Star Healthcare Network
- Three Rivers Provider Network
- Tricare/Humana Military Health Services/CHAMPVA
- United Healthcare of the Mid-Atlantic
- UPMC MCAID/CHIP PA DE
- US Family Health Plan
- Wellpoint Maryland Medcaid
- Anemia
- Blood and Bone Marrow Transplantation
- Blood Disorders
- Cancer Care
- Leukemia
- Lymphoma
- Neuroblastoma
- Neutropenia
- Retinoblastoma
Medical Interests
- Acute myeloid leukemia (AML)
-
γδ CD8+ T cells and novel genetic variants in ZAP70 deficiency; Pediatric Allergy and Immunology; (2023).
View Full Publication -
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium; The Lancet; (2023).
View Full Publication -
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia; Infection Control & Hospital Epidemiology; (2023).
View Full Publication -
Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias; Blood Advances; (2023).
View Full Publication -
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions; Journal of Allergy and Clinical Immunology; (2023).
View Full Publication -
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC; Blood; (2022).
View Full Publication -
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease; Blood; (2022).
View Full Publication -
A clinician’s guide to HLA matching in allogeneic hematopoietic stem cell transplant; Human Immunology; (2022).
View Full Publication -
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management after Chemotherapy for Pediatric Acute Myeloid Leukemia; JAMA Network Open; (2021).
View Full Publication -
Immune profile differences between chronic GVHD and late acute GVHD: Results of the ABLE/PBMTC 1202 studies; Blood; (2020).
View Full Publication -
Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey; Frontiers in Immunology; (2020).
View Full Publication -
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria; Blood; (2019).
View Full Publication -
The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018); Journal of Allergy and Clinical Immunology; (2019).
View Full Publication -
RHEGMATOGENOUS RETINAL DETACHMENT after INTRAARTERIAL CHEMOTHERAPY for RETINOBLASTOMA: The 2016 Founders Award Lecture; Retina; (2017).
View Full Publication -
Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy. Outcomes based on the international classification of retinoblastoma; Asia-Pacific Journal of Ophthalmology; (2016).
View Full Publication -
Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: A case report; Biomarker Research; (2016).
View Full Publication -
Retinoblastoma control with primary intra-arterial chemotherapy: Outcomes before and during the intravitreal chemotherapy era; Journal of Pediatric Ophthalmology and Strabismus; (2016).
View Full Publication -
Challenges in converting Acute Myeloid Leukemia (AML) genomics into AML clinical trials; Journal of Clinical Oncology; (2015).
View Full Publication -
Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: Evidence from four decades of US population data; Cancer Epidemiology; (2015).
View Full Publication -
Intra-arterial chemotherapy for retinoblastoma in 70 eyes: Outcomes based on the international classification of retinoblastoma; Ophthalmology; (2014).
View Full Publication -
Targeted retinoblastoma management: When to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy; Current Opinion in Ophthalmology; (2014).
View Full Publication -
Abnormalities of the large ribosomal subunit protein, rpl35a, in diamond-blaekfan anemia; Blood; (2008).
View Full Publication
- English